94952-47-3 Usage
Uses
Used in Pharmaceutical Industry:
2-BROMO-1-(5-CHLOROPYRIDIN-2-YL)ETHANONE is used as an intermediate in the synthesis of various pharmaceuticals for its ability to participate in a wide range of chemical reactions. Its reactivity allows for the development of new drug molecules with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-BROMO-1-(5-CHLOROPYRIDIN-2-YL)ETHANONE is utilized as a building block for the synthesis of complex organic molecules, which can be further used in the development of agrochemicals such as pesticides and herbicides. Its versatility in organic synthesis contributes to the creation of novel and effective agrochemical products.
Used in Organic Synthesis:
2-BROMO-1-(5-CHLOROPYRIDIN-2-YL)ETHANONE is an important and versatile chemical compound in the field of organic synthesis. Its reactivity and ability to form various chemical bonds make it a valuable component in the synthesis of more complex organic molecules, which can be used in a wide range of applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 94952-47-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,4,9,5 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 94952-47:
(7*9)+(6*4)+(5*9)+(4*5)+(3*2)+(2*4)+(1*7)=173
173 % 10 = 3
So 94952-47-3 is a valid CAS Registry Number.
94952-47-3Relevant articles and documents
Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents
-
, (2008/06/13)
This invention provides a compound of the following formula: or the pharmaceutically acceptable salts thereof wherein Z is tetrazolyl optionally substituted with a substituent selected from C1-4 alkyl and halosubstituted C1-4 alkyl;A is C1-6 alkylene; Q is selected from the following groups: (a) optionally substituted phenyl; (b) an optionally substituted, partially saturated, fully saturated or fully unsaturated five to six membered monocyclic group having one to three heteroatoms; and (c) an optionally substituted, bicyclic group consisting of two fused partially saturated, fully saturated or fully unsaturated five or six membered rings independently and optionally having one to four heteroatoms; X is halogen, C1-4 alkyl, halosubstituted C1-4 alkyl, OH, C1-4 alkoxy or the like; and n is 0, 1, 2, 3 or 4. This invention also provides a pharmaceutical composition useful for the treatment of a medical condition in which prostaglandins are implicated as pathogens.
